"Analgesics in Uzbekistan" is now available at Fast Market Research

From: Fast Market Research, Inc.
Published: Mon Dec 07 2015

Analgesics remains an important part of consumer health. Accounting for 8% of total retail sales in 2015, analgesics recorded a slight loss of share within the overall consumer health market. The reason was the appearance of competitively priced domestic products and sharp price growth among imports, which generated lower retail volume sales. Other than that, the biggest force to drive sales of analgesics was consumers’ tendency to self-medicate.

Competitive Landscape

Bristol-Myers Squibb Co continue to lead retail sales of analgesics, and held a 30% share of total value sales in 2015 despite losing one percentage point from 2014. Sharp price growth among imported brands, including the company’s popular Fervex (14%) and Efferalgan (14%) brands, as well as consumer loyalty gained throughout the review period ensured its leadership in 2015. GlaxoSmithKline Plc accounted for 22% in the year, holding second position thanks to its popular Panadol (9%), Coldrex (6%) and Solpadeine (4%) brands. Radiks NPP with its Paracetamol (3%) and other systemic analgesics accounted for third with 11%.

Full Report Details at
- http://www.fastmr.com/prod/1082100_analgesics_uzbekistan.aspx?afid=301

Industry Prospects

The demand for analgesics will continue to grow in line with the population in the forecast period. However, the increasing migration of people to foreign countries and declining birth rates are expected to slow down volume sales growth in 2015-2020. Notable change will occur only in shares, as domestic manufacturers will strengthen their positions at the expense of decreasing import sales. Again, analgesics will not record high sales growth, as a value CAGR of 2% at constant 2015 prices is projected for the forecast period.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Uzbekistan with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in Uzbekistan, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in Uzbekistan market research report includes:

* Analysis of key supply-side and demand trends
* Detailed segmentation of international and local products
* Historic volumes and values, company and brand market shares
* Five year forecasts of market trends and market growth
* Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

* What is the market size of Analgesics in Uzbekistan?
* What are the major brands in Uzbekistan?

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Consumer Health in Uzbekistan
- Analgesics in South Korea
- Analgesics in Tunisia
- Analgesics in the United Arab Emirates
- Analgesics in Mexico

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »